Comparing aerobic exercise with yoga for weight loss in overweight adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to determine if adding yoga to a behavioral weight loss program enhances weight loss compared to a program that includes only aerobic exercise. Participants will engage in either aerobic exercise alone or a combination of aerobic exercise and yoga, while also receiving dietary guidance and behavioral sessions. The study will assess differences in weight loss, physical activity levels, and changes in body composition between the two groups. The findings could provide insights into the effectiveness of integrating yoga into weight loss interventions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Both males and females of all race/ethnic groups are eligible for participation in this study.
* at least 18 years of age. The investigators will not limit enrollment based on an upper age provided that the participant meets the other eligibility requirements.
* Body mass index (BMI) of at least 25.0 kg/m2. The investigators will not limit enrollment based on an upper BMI level provided that the participant meets the other eligibility requirements. However, maximal weight to be eligible will be 350 pounds to meet the weight requirements for the equipment that will be used in this study.
* Ability to provide informed consent prior to participation in this study.
* Ability to provide clearance from their primary care physician to engage in the diet and physical activity components of the weight loss intervention.

Exclusion Criteria:

* Report moderate-to-vigorous exercise on \>3 days/week or a total of \>60 min/week over the past 3 months.
* Engaging in any style of yoga on an average of at least 1 day/week over the past 3 months.
* Report weight loss of 3% or more or participating in a weight reduction diet in the past 3 months.
* Currently prescribed an anti-obesity medication.
* Females who are pregnant or breastfeeding or reporting a planned pregnancy during the study period.
* History of bariatric surgery.
* Report a current medical condition or treatment for a medical condition that could affect body weight.
* Current congestive heart failure, angina, uncontrolled arrhythmia, symptoms indicative of an increased acute risk for a cardiovascular event, prior myocardial infarction, coronary artery bypass grafting or angioplasty, conditions requiring chronic anticoagulation (i.e., recent or recurrent DVT).
* Resting systolic blood pressure of 160 mmHg or more or resting diastolic blood pressure of 100 mmHg or more. If medicated for blood pressure control, the medication dose needs to be stable for at least 6 months.
* Eating disorders that would contraindicate weight loss or physical activity.
* Alcohol or substance abuse.
* Current psychological condition that is untreated, hospitalization for a psychological condition within the past 12 months, or not being on a stable dose of treatment for at least 6 months.
* Report plans to relocate to a location not accessible to the study site or having employment, personal, or travel commitments that prohibit attendance at scheduled intervention sessions or assessments.

Where it's running

• University of Kansas Medical Center
  Kansas City, Kansas, United States Recruiting

Study contacts

• Principal investigator: John M. Jakicic, PhD — University of Kansas Medical Center
• Study coordinator: John M Jakicic, PhD
• Email: jjakicic@kumc.edu
• Phone: 913-588-9078

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• IBI3046 in Overweight or Obesity

  This study tests how safe and tolerable IBI3046 is in adults with overweight or obesity in China.

  Recruiting Phase 1 Innovent Biologics (Suzhou) Co. Ltd. · Beijing, Beijing Municipality · NCT07809945

• Sleep behavioral program for adolescents with overweight or obesity

  This trial will test whether adding a sleep-focused behavioral program to usual weight treatment helps teens (13–17) with overweight or obesity who have poor sleep improve body composition and health markers.

  Recruiting University of Beira Interior · Covilha and 1 other locations · NCT07255274

• Robotic versus laparoscopic conversion to RYGB for revision bariatric surgery

  We will see if robotic surgery or laparoscopy leads to fewer postoperative complications for people having revision bariatric surgery converted to RYGB.

  Recruiting GCS Ramsay Santé pour l'Enseignement et la Recherche · Lyon and 1 other locations · NCT07180316

• Bone health, vitamin D, weight, and fractures in children

  See if blood markers (alkaline phosphatase, calcium, PTH, vitamin D), body weight, and calcium intake are linked to fractures in children aged 3–15 after low-energy trauma.

  Recruiting at 2 sites Paracelsus Medical University · Brixen, Bolzano and 1 other locations · NCT07143552

• Efsubaglutide alfa for adults with overweight or obesity (SPARKLE)

  This trial will test whether efsubaglutide alfa injections given weekly or every few weeks help adults with overweight or obesity lose weight safely.

  Recruiting at 5 sites Phase 2 Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. · Brookvale and 4 other locations · NCT07114419

• Cardiovascular health in children and young adults with chronic conditions

  This project will see if children and young adults (ages 6-25) with chronic health conditions show early signs of aging in large and small blood vessels using noninvasive imaging and clinical tests.

  Recruiting Semmelweis University · Budapest and 2 other locations · NCT07086989

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.